Navigation Links
Amsterdam Molecular Therapeutics Part of Next Biotech Index
Date:4/8/2008

subject to known and unknown risks and can be affected by factors that are beyond the control of AMT. Actual results could differ materially from current expectations due to a number of factors and uncertainties affecting AMT's business, including, but not limited to, the timely commencement and success of AMT's clinical trials and research endeavors, delays in receiving U.S. Food and Drug Administration or other regulatory approvals (i.e. EMEA, Health Canada), market acceptance of AMT's products, effectiveness of AMT's marketing and sales efforts, development of competing therapies and/or technologies, the terms of any future strategic alliances, the need for additional capital, the inability to obtain, or meet, conditions imposed for required governmental and regulatory approvals and consents. AMT expressly disclaims any intent or obligation to update these forward-looking statements except as required by law. For a more detailed description of the risk factors and uncertainties affecting AMT, refer to the prospectus of AMT's initial public offering on June 20, 2007, and AMT's public announcements made from time to time.


'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
2. Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board
3. Amsterdam Molecular Therapeutics Reports Full Year Results 2007
4. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
5. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
6. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
7. Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision
8. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
9. ABR-Affinity BioReagents to Exhibit at the Society for Biomolecular Sciences in St. Louis, April 6 - 10, 2008
10. Sigma-Aldrich Partners With Sunset Molecular Discovery to Expand Your Favorite Gene Search Tool
11. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets  has announced the addition of the ... report to their offering. This report ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Asia-Pacific , and Rest of ... 2012 through 2020. Market data and analytics are derived from ...
(Date:8/19/2014)... In November 2012, the European Union (EU) ... (PBRER) in a new PSUR – responding to the increasing ... of a drug. Adopted in many regions, the main objectives ... a comprehensive and critical analysis of new or emerging information ... any new evidence of the potential benefits of a drug; ...
(Date:8/18/2014)... 2014) -- A new therapy developed by researchers ... College of Medicine and Columbia University Medical Center ... interventional cardiovascular disease treatment. , The researchers ... molecular therapy could selectively inhibit blood vessel re-narrowing ... procedure using a balloon catheter to open narrowed ...
(Date:8/18/2014)... HIV Infection Drug Market and Pipeline Insight is a ... infection and the number of deaths due to AIDS has ... the globe. It has been estimated that the death rate ... with the rates for children being even much lower. A ... has been the improved access to antiretroviral drugs and therapy ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4
... Feb. 4 Art,s Way Manufacturing, Inc. (Nasdaq: ... subsidiary, Art,s Way Scientific, Inc. - Buildings For ... - http://www.buildingsforscience.com/ The new site, reflective ... enhanced, clean and more user-friendly.Art,s Way Scientific ( ...
... (Nasdaq: KNDL ) announced today that it will ... closes on Tuesday, Feb. 24, 2009. The Company will host ... 25 at 8:30 a.m. Eastern Time. A question and answer ... participate in the telephone conference call, interested parties in the ...
... Patients Achieved an Objective Tumor Response by End of ... Inc. (Nasdaq: PPHM ) today reported that ... endpoint in the first stage of its ongoing Phase ... cancer (NSCLC). The open-label, Simon two-stage study is ...
Cached Biology Technology:Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 3Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call 2Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study 2Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study 3Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study 4
(Date:8/19/2014)... DIEGO, Calif. (August 19, 2014) Daylight was breaking ... MY Hanse Explorer. Between sips, about a dozen scientists ... and slip below the surface to collect water samples ... would tinker with the whirring gizmos and delicate machinery ... single goal: Be the first research group to bring ...
(Date:8/18/2014)... person,s gut may protect against or increase susceptibility to ... bacterial intestinal inflammation, according research published this week in ... American Society for Microbiology. The study also found that ... one,s gut bacteria composition. , "It has been known ... in the gut, can protect a person from colonization ...
(Date:8/18/2014)... UT Southwestern Medical Center have found a new way that ... known as long non-coding RNA. , The internal body clocks, ... functions, from waking and sleeping to body temperature and hunger. ... influenced by external cues such as light and temperature. , ... many organisms, what they do in the body, and how ...
Breaking Biology News(10 mins):Sequencing at sea 2Sequencing at sea 3What's in your gut? Certain bacteria may influence susceptibility to infection 2Researchers obtain key insights into how the internal body clock is tuned 2Researchers obtain key insights into how the internal body clock is tuned 3
... seeking to detect bioterrorism attacks, doctors diagnosing diseases ... a new ally in a Lawrence Livermore National ... as the Lawrence Livermore Microbial Detection Array (LLMDA), ... to detect within 24 hours any virus or ...
... prestigious Pierre Delmas Prize: An ESCEO-IOF/Servier Achievement Award was ... at the Claude Bernard University of Lyon, France. ... honour of the late Pierre D. Delmas, the world ... (IOF). The grant of 40,000 Euros, courtesy of Servier, ...
... A prescription drug already approved to treat genital warts and ... effectiveness of future vaccines for bacterial and viral diseases, such ... appear in ACS, Molecular Pharmaceutics , a bi-monthly journal. ... Research Center and UC-Berkeley note that vaccines prepared from weakened ...
Cached Biology News:New LLNL detection technology identifies bacteria, viruses, other organisms within 24 hours 2New LLNL detection technology identifies bacteria, viruses, other organisms within 24 hours 3Winner of Pierre Delmas Prize announced at World Congress on Osteoporosis 2010 2
Normal human serum, single donor...
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
Human IL-17D Affinity Purified Polyclonal Ab...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Biology Products: